Drug-Coated Balloon (DCB)
Sponsors
Medtronic Endovascular, Second Affiliated Hospital, School of Medicine, Zhejiang University, Shanghai 10th People's Hospital, Xijing Hospital
Conditions
Acute Coronary Syndromes (ACS)Coronary Artery DiseaseDiabete Type 2Femoral Artery OcclusionFemoral Artery StenosisPeripheral Arterial Disease (PAD)Popliteal Artery OcclusionPopliteal Artery Stenosis
Unknown Phase
Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease
CompletedNCT01175850
Start: 2010-09-30End: 2017-04-30Updated: 2017-05-16
IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA)
CompletedNCT01566461
Start: 2012-03-31End: 2018-05-31Updated: 2019-02-12
Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction
RecruitingNCT06742125
Start: 2025-05-31End: 2032-01-01Target: 1244Updated: 2026-01-29
DCB for CAD With Type 2 Diabetes
Not yet recruitingNCT07009938
Start: 2025-07-01End: 2028-07-01Target: 1000Updated: 2025-06-08
A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus Burden
RecruitingNCT07806370
Start: 2019-01-01End: 2028-01-31Target: 668Updated: 2026-09-08